Intra-patient neuraminidase mutations in avian H5N1 influenza virus reduce sialidase activity to complement weaker hemagglutinin binding and facilitate human infection. [PDF]
Watanabe Y +15 more
europepmc +1 more source
An overview of HPAI H5N1 clade 2.3.4.4b and its emerging threat in mainland Australia: Identified knowledge gaps. [PDF]
Zhang P, MacIntyre CR.
europepmc +1 more source
The expanding H5N1 avian influenza panzootic causes high mortality of skuas in Antarctica. [PDF]
Iervolino M +21 more
europepmc +1 more source
Avian Influenza Viruses: Global Panzootic, Host Range Expansion and Emerging One-Health Threats. [PDF]
Bruno L +7 more
europepmc +1 more source
One confirmed and one potential human case of influenza A(H5N1) detected through an expanded subtyping protocol. [PDF]
Higerd-Rusli GP +7 more
europepmc +1 more source
Detection of Antibodies Specific to H5 Avian Influenza Virus in a Sheep in Norway, June 2024, 11 Months After an Outbreak of Highly Pathogenic Avian Influenza in a Nearby Seabird Colony. [PDF]
Fosse JH +6 more
europepmc +1 more source
Highly Pathogenic Avian Influenza: Tracking the Progression from IAV (H5N1) to IAV (H7N9) and Preparing for Emerging Challenges. [PDF]
El-Bidawy MH +9 more
europepmc +1 more source
DNA vaccines targeting hemagglutinin from 18 subtypes of influenza A virus to antigen-presenting cells confer broad protection. [PDF]
Anderson AM +5 more
europepmc +1 more source
Serological Evidence of Highly Pathogenic Avian Influenza (H5N1) in Invasive Wild Pigs in Western Canada. [PDF]
Ley Garcia O +8 more
europepmc +1 more source
Recent advances in lateral flow devices and point-of-care diagnostics for highly pathogenic avian influenza A viruses. [PDF]
Lin M-W +4 more
europepmc +1 more source

